ABT-199

Item number	Size	Manual	Delivery time	Price
LKT-A0776.1	1 mg	-	3 - 8 business days*	69.00€
LKT-A0776.5	5 mg	-	3 - 8 business days*	132.00€
LKT-A0776.10	10 mg	-	3 - 8 business days*	229.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

ABT-199 is a BH3 mimetic that inhibits Bcl-2 but does not affect Bcl-xl. ABT-199 exhibits... more

Close menu

Product information "ABT-199"

ABT-199 is a BH3 mimetic that inhibits Bcl-2 but does not affect Bcl-xl. ABT-199 exhibits anticancer chemotherapeutic activity, inducing Bim-mediated apoptosis in chronic lymphocytic leukemia (CLL) cells. ABT-199 also induces cell death and inhibits tumor growth in acute myelogenous leukemia (AML) models in vitro, ex vivo, and in vivo. ABT-199 is currently under examination as a potential treatment for CLL.

Keywords:	GDC-0199
Supplier:	LKT Laboratories
Supplier-Nr:	A0776

Properties

Application:	BH3 mimetic, Bcl-2 inhibitor
MW:	868.44 D
Purity:	>98%
Format:	Solid

Database Information

CAS :	1257044-40-8\| Matching products
KEGG ID :	K02161 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

View product citations for antibody A0776 on CiteAb

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "ABT-199"

Write a review